National Dentex Corporation (NASDAQ: NADX), one of the largest
owner/operators of dental laboratories in the United States, today
announced sales and earnings for the six months and second quarter
ended June 30, 2009. Sales for the second quarter of 2009 totaled
$42,755,000 compared with $44,580,000 a year earlier. Net income
for the second quarter was $2,330,000, or $.40 per share on a
diluted basis, compared to $1,937,000, or $.34 per share on a
diluted basis for the same quarter in 2008.
For the six month period ended June 30, 2009, sales were
$84,015,000 compared to $88,108,000 for the same period in 2008.
Net income was $4,389,000 for the six month period ended June 30,
2009, or $.77 per share on a diluted basis, compared to $3,618,000
or $.64 per share on a diluted basis in the year-ago period.
David Brown, President and Chief Executive Officer stated “In
this very challenging consumer market, we are pleased to highlight
another quarter of positive growth in our bottom line. Today, we
reported an increase in net income of $393,000 for the second
quarter of 2009, or a 20.3% increase, as compared to the second
quarter of 2008, resulting in an overall gain of $771,000 in net
income for the six month period ended June 30, 2009, as compared to
the same period of 2008. Despite sales declines of 5.2% in the
first quarter of 2009 and 4.1% in the second quarter of 2009, we
attained this positive growth in net income primarily through our
ongoing efforts to manage our cost structure, as our dental
laboratories are successfully executing our cost containment
initiatives, while at the same time improving laboratory
productivity. In addition, our results benefited from declines in
commodity prices, particularly in materials costs and delivery
expense. We attribute the decline in sales in recent quarters to
some patients’ deferral of discretionary dental services due to the
economic recession. As the economy comes out of this recessionary
period, we anticipate that our new cost structure and improvements
in productivity will allow us to capitalize on the expected
increase in demand for dental services, as patients who deferred
these types of expenditures no longer do so.”
About National Dentex
National Dentex Corporation serves an active customer base of
over 24,000 dentists through 46 dental laboratories located in 30
states and one Canadian province. National Dentex’s dental
laboratories provide a full range of custom-made dental prosthetic
appliances, including dentures, crowns, and fixed bridges, and
other dental specialties.
Safe Harbor Statement
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995
as contained in Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. You can
identify these statements by the fact that they use words such as
"anticipate," "believe," "estimate," "expect," "intend," "project,"
"plan," "outlook," and other words and terms of similar meaning.
These forward-looking statements are based on our current
expectations, beliefs, assumptions, estimates, forecasts and
projections about the industry and markets in which National Dentex
operates. The forward-looking statements contained in this release
are not guarantees of future performance and involve certain risks,
uncertainties and assumptions that are difficult to predict.
Therefore, actual outcomes and results may differ materially from
what is expressed in such forward-looking statements. Important
factors that may affect future outcomes and results include the
timing, duration and effects of changes in overall economic
conditions and other developments that directly or indirectly
affect consumer decisions as to whether and when to have dental
procedures performed, including the current economic recession,
high unemployment rates and credit market disruptions; National
Dentex’s ability to acquire new laboratories on terms and
conditions acceptable to it and its capacity to integrate and
successfully operate previously acquired laboratories; governmental
regulation of health care; trends in the dental industry towards
managed care; increases in labor, benefits and material costs;
product development risks; technological innovations; competition
from other dental laboratories, including increased competition
from dental laboratories located in foreign countries with lower
labor and benefit costs, such as China; National Dentex’s ability
to attract, retain and motivate qualified personnel; changes in the
cost or availability of raw materials, particularly precious metals
like gold and palladium; any impairment in the carrying value of
goodwill or other acquired intangibles; National Dentex’s ability
to access the credit markets on commercially reasonable terms;
compliance with evolving federal securities, accounting, and
marketplace rules and regulations applicable to publicly-traded
companies on the NASDAQ Global Market; and other risks indicated
from time to time in National Dentex’s filings with the Securities
and Exchange Commission, particularly under Item 1A, “Risk Factors”
of National Dentex’s most recently filed Annual Report on Form 10-K
and our other periodic reports filed with the SEC. National Dentex
assumes no obligation to update the information included in this
press release, whether as a result of new information, future
events or otherwise.
National Dentex
Corporation
Earnings Results
(Unaudited)
(In Thousands, except per share
data)
Quarter Ended Six Months Ended
June 30,
June 30, 2008 2009
2008 2009 Net Sales $
44,580 $ 42,755 $ 88,108 $ 84,015 Cost of Goods Sold
25,915 23,927
51,233 47,565 Gross Profit 18,665
18,828 36,875 36,450 Operating Expenses
14,804 14,451
29,624 28,174 Operating Income
3,861 4,377 7,251 8,276 Other Expense 210 230 369 450
Interest Expense
513 380
1,021 725 Income Before Tax
3,138 3,767 5,861 7,101 Income Taxes
1,201 1,437
2,243 2,712 Net Income
$ 1,937 $ 2,330
$ 3,618 $ 4,389
Weighted Average
Shares Outstanding:
- Basic 5,630 5,736 5,608 5,700 - Diluted 5,652 5,756 5,637 5,700
Net Income per Share: - Basic $ 0.34 $ 0.41 $ 0.65 $ 0.77 -
Diluted $ 0.34 $ 0.40 $ 0.64 $ 0.77
National Dentex
Corporation
Selected Balance Sheet
Data
(Unaudited)
(In thousands)
December 31,2008
June 30,2009
Cash and Equivalents $ 2,110 $ 1,751 Accounts Receivable –
net 19,228 19,284 Current Assets 33,019 33,049 Current
Liabilities
23,492 20,859
Working Capital 9,527 12,190 Total Assets 161,515 160,143
Long Term Obligations 47,531 43,640 Stockholders’ Equity $
90,492 $ 95,644
National Dentex (NASDAQ:NADX)
Historical Stock Chart
From Feb 2025 to Mar 2025
National Dentex (NASDAQ:NADX)
Historical Stock Chart
From Mar 2024 to Mar 2025